Roche's Webcast Replay on data presented at AAN 2019
Roche has hosted a live audio webcast and conference call on Monday, 13 May 2019.
Karl Mahler, Head of Investor Relations
- Overview of Roche key data at AAN covering new analysis from Ocrevus, satralizumab SakuraSky phase III data, risdiplam one year part I FIREFISH and SUNFISH data and dose selection data for the phase III study in Huntington's Disease
Paulo Fontoura, Global Head Neuroscience and Rare Diseases Clinical Development
- Roche Neuroscience and Rare Disease franchise update
Karsten Jung, Therapeutic Area Head Neuroscience and Rare Diseases
Please register to access the webcast